{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:21:38Z","timestamp":1794496898525,"version":"4.9.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154405","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:03:34Z","timestamp":1789023814000},"page":"154405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["PDK1 signaling in cancer: Current status and future perspectives"],"prefix":"10.1016","volume":"382","author":[{"given":"Darshana Ballagere","family":"Honnasiddappa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohankumar","family":"Ramar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tincy","family":"Biju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallikarjun","family":"Sajjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidananda","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayan Kumar","family":"Mahadeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvaraj","family":"Kunjiappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodar Nayak","family":"Ammunje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuraman","family":"Pavadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154405_bb0005","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1021\/jm4000227","article-title":"Selective 3-phosphoinositide-dependent kinase 1 (PDK1) inhibitors: dissecting the function and pharmacology of PDK1: miniperspective","volume":"56","author":"Medina","year":"2013","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0010","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41467-022-28910-8","article-title":"S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.154405_bb0015","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2174\/092986711796011238","article-title":"Targeting PDK1 in cancer","volume":"18","author":"Raimondi","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030746","article-title":"Elevated PDK1 expression drives PI3K\/AKT\/MTOR signaling promotes radiation-resistant and dedifferentiated phenotype of hepatocellular carcinoma","volume":"9","author":"Bamodu","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030811","article-title":"The landscape of PDK1 in breast cancer","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9030025","article-title":"Serine\/threonine kinase 3-phosphoinositide-dependent protein kinase-1 (PDK1) as a key regulator of cell migration and cancer dissemination","volume":"9","author":"Di Blasio","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2026.1767926","article-title":"Phosphoinositide-dependent kinase 1 (PDK1) in cancer: molecular insights and therapeutic strategies","volume":"14","author":"Algheribe","year":"2026","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/14756366.2018.1553167","article-title":"The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1","volume":"34","author":"Xu","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2016.06.004","article-title":"PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3K\u03b1 inhibition","volume":"30","author":"Castel","year":"2016","journal-title":"Cancer Cell"},{"issue":"789","key":"10.1016\/j.ijbiomac.2026.154405_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.add3184","article-title":"Modulation of the substrate specificity of the kinase PDK1 by distinct conformations of the full-length protein","volume":"16","author":"Sacerdoti","year":"2023","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030703","article-title":"Current state and future challenges for PI3K inhibitors in cancer therapy","volume":"15","author":"Sirico","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190854","article-title":"Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy","volume":"13","author":"Sathe","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154405_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188971","article-title":"Master kinase PDK1 in tumorigenesis","volume":"1878","author":"Zheng","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"6016","key":"10.1016\/j.ijbiomac.2026.154405_bb0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/315239a0","article-title":"Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation","volume":"315","author":"Whitman","year":"1985","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154405_bb0075","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0960-9822(06)00336-8","article-title":"3-phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0960-9822(98)70037-5","article-title":"3-phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro","volume":"8","author":"Alessi","year":"1998","journal-title":"Curr. Biol."},{"issue":"5351","key":"10.1016\/j.ijbiomac.2026.154405_bb0085","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.279.5351.707","article-title":"Phosphorylation and activation of p70s6k by PDK1","volume":"279","author":"Pullen","year":"1998","journal-title":"Science"},{"issue":"26","key":"10.1016\/j.ijbiomac.2026.154405_bb0090","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.1074\/jbc.273.26.16621","article-title":"Regulation of the p70 S6 kinase by phosphorylation in vivo: analysis using site-specific anti-phosphopeptide antibodies","volume":"273","author":"Weng","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0095","series-title":"Discovery of PDKI, One of the Missing Links in Insulin Signal Transduction","author":"Alessi","year":"2001"},{"issue":"5385","key":"10.1016\/j.ijbiomac.2026.154405_bb0100","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1126\/science.281.5385.2042","article-title":"Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1","volume":"281","author":"Le Good","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm2822","article-title":"The nuts and bolts of AGC protein kinases","volume":"11","author":"Pearce","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase b\u03b1","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0115","series-title":"Phosphoinositide 3-kinase in Health and Disease: Volume 1","first-page":"9","article-title":"PDK1: the major transducer of PI 3-kinase actions","author":"Bayascas","year":"2010"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154405_bb0120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/emboj\/19.5.979","article-title":"Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA","volume":"19","author":"Biondi","year":"2000","journal-title":"EMBO J."},{"issue":"5351","key":"10.1016\/j.ijbiomac.2026.154405_bb0125","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1126\/science.279.5351.710","article-title":"Protein kinase B kinases that mediate phosphatidylinositol 3, 4, 5-trisphosphate-dependent activation of protein kinase B","volume":"279","author":"Stephens","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcdb.2003.12.022","article-title":"PDK1, the master regulator of AGC kinase signal transduction","author":"Mora","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.154405_bb0135","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1042\/BCJ20220396","article-title":"The choreography of protein kinase PDK1 and its diverse substrate dance partners","volume":"480","author":"Leroux","year":"2023","journal-title":"Biochem. J."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.154405_bb0140","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1093\/emboj\/cdf437","article-title":"High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site","volume":"21","author":"Biondi","year":"2002","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj3420287","article-title":"Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo","volume":"342","author":"Casamayor","year":"1999","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0150","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41467-022-29368-4","article-title":"Activation of the essential kinase PDK1 by phosphoinositide-driven trans-autophosphorylation","volume":"13","author":"Levina","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0155","doi-asserted-by":"crossref","first-page":"14527","DOI":"10.1038\/s41598-019-50742-8","article-title":"A complex interplay of anionic phospholipid binding regulates 3\u2032-phosphoinositide-dependent-kinase-1 homodimer activation","volume":"9","author":"Heras-Mart\u00ednez","year":"2019","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.154405_bb0160","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1242\/jcs.02617","article-title":"In vivo role of the phosphate groove of PDK1 defined by knockin mutation","volume":"118","author":"Collins","year":"2005","journal-title":"J. Cell Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154405_bb0165","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.chembiol.2012.07.017","article-title":"Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site","volume":"19","author":"Busschots","year":"2012","journal-title":"Chem. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bioorg.2006.05.002","article-title":"Role of the PH domain in regulating in vitro autophosphorylation events required for reconstitution of PDK1 catalytic activity","volume":"34","author":"Gao","year":"2006","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri2036","article-title":"PI3K\u03b4 and PI3K\u03b3: partners in crime in inflammation in rheumatoid arthritis and beyond?","volume":"7","author":"Rommel","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.154405_bb0180","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1021\/acs.jcim.4c01392","article-title":"Capturing autoinhibited PDK1 reveals the linker\u2019s regulatory role, informing innovative inhibitor design","volume":"64","author":"Xu","year":"2024","journal-title":"J. Chem. Inf. Model."},{"issue":"29","key":"10.1016\/j.ijbiomac.2026.154405_bb0185","doi-asserted-by":"crossref","first-page":"25186","DOI":"10.1021\/acsomega.2c02020","article-title":"Molecular insights into the regulation of 3-phosphoinositide-dependent protein kinase 1: modeling the interaction between the kinase and the pleckstrin homology domains","volume":"7","author":"Garcia-Viloca","year":"2022","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0190","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/BST20253059","article-title":"Molecular insight to the role of the phosphoinositide PIP3 in regulating the protein kinases Akt, PDK1, and BTK","volume":"53","author":"Shaw","year":"2025","journal-title":"Biochem. Soc. Trans."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.154405_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164133","article-title":"Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER\u2013mitochondria interface in oncogene-driven NSCLC","volume":"13","author":"De Rosa","year":"2021","journal-title":"Cancers"},{"issue":"5573","key":"10.1016\/j.ijbiomac.2026.154405_bb0200","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154405_bb0205","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s13046-024-03207-4","article-title":"AKT kinases as therapeutic targets","volume":"43","author":"Hassan","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154405_bb0215","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004686","article-title":"C-Src regulates Akt signaling in response to ghrelin via \u03b2-arrestin signaling-independent and-dependent mechanisms","volume":"4","author":"Lodeiro","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/BJ20101732","article-title":"Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1","volume":"433","author":"Najafov","year":"2011","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154405_bb0230","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1128\/MCB.00144-14","article-title":"Phosphoinositide-dependent kinase 1 and mTORC2 synergistically maintain postnatal heart growth and heart function in mice","volume":"34","author":"Zhao","year":"2014","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041199","article-title":"Distinct roles of mTOR targets S6K1 and S6K2 in breast cancer","volume":"21","author":"Sridharan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0240","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cell.2005.10.024","article-title":"mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events","volume":"123","author":"Holz","year":"2005","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BJ20081668","article-title":"mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum-and glucocorticoid-induced protein kinase 1 (SGK1)","volume":"416","author":"Garc\u00eda-Mart\u00ednez","year":"2008","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0250","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/BJ20110289","article-title":"Regulation and function of the RSK family of protein kinases","volume":"441","author":"Romeo","year":"2012","journal-title":"Biochem. J."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.154405_bb0255","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.15252\/embj.201693929","article-title":"The hVps34-SGK3 pathway alleviates sustained PI3K\/Akt inhibition by stimulating mTORC1 and tumour growth","volume":"35","author":"Bago","year":"2016","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0260","first-page":"178","article-title":"PDK1: a signaling hub for cell migration and tumor invasion","volume":"1856","author":"Gagliardi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tcb.2008.10.003","article-title":"The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development","volume":"19","author":"Morrison","year":"2009","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0270","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/BJ20101024","article-title":"Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)","volume":"431","author":"Pearce","year":"2010","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0275","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1128\/MCB.19.3.1661","article-title":"p50 cdc37 acting in concert with Hsp90 is required for Raf-1 function","volume":"19","author":"Grammatikakis","year":"1999","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0280","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ncb1675","article-title":"PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE","volume":"10","author":"Pinner","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154405_bb0285","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ncb1019","article-title":"Differing modes of tumour cell invasion have distinct requirements for rho\/ROCK signalling and extracellular proteolysis","volume":"5","author":"Sahai","year":"2003","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0290","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20121287","article-title":"Akt is efficiently activated by PIF-pocket-and PtdIns (3, 4, 5) P 3-dependent mechanisms leading to resistance to PDK1 inhibitors","volume":"448","author":"Najafov","year":"2012","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0300","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.coph.2008.08.004","article-title":"Targeting the PI3K\u2013AKT\u2013mTOR pathway: progress, pitfalls, and promises","volume":"8","author":"Yap","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154405_bb0305","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.7150\/jca.92521","article-title":"Disruption of Autophagic flux and treatment with the PDPK1 inhibitor GSK2334470 synergistically inhibit renal cell carcinoma pathogenesis","volume":"15","author":"Zhou","year":"2024","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154405_bb0310","first-page":"2951","article-title":"PDK1 inhibitor GSK2334470 synergizes with proteasome inhibitor MG-132 in multiple myeloma cells by inhibiting full AKT activity and increasing nuclear accumulation of the PTEN protein","volume":"39","author":"Zhang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0315","series-title":"Investigation of the Mechanisms and Therapeutic Implications of Crosstalk between G-Protein-Coupled Receptors and the Epidermal Growth Factor Receptor in HNSCC, University of Pittsburgh","author":"Bhola","year":"2009"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154405_bb0320","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41419-022-05081-4","article-title":"Beyond controlling cell size: functional analyses of S6K in tumorigenesis","volume":"13","author":"Wu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.154405_bb0325","doi-asserted-by":"crossref","first-page":"39185","DOI":"10.18632\/oncotarget.16642","article-title":"PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1\/C2 inhibitor PP242","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0330","series-title":"Funktionelle Charakterisierung der Serum-und Glukokortikoid-induzierbaren Proteinkinase Sgk1","author":"Engelsberg","year":"2007"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0335","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10409238.2018.1442408","article-title":"Protein kinase C: perfectly balanced","volume":"53","author":"Newton","year":"2018","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"44","key":"10.1016\/j.ijbiomac.2026.154405_bb0340","doi-asserted-by":"crossref","first-page":"30318","DOI":"10.1074\/jbc.M109.051151","article-title":"Regulation of the interaction between protein kinase C-related protein kinase 2 (PRK2) and its upstream kinase, 3-phosphoinositide-dependent protein kinase 1 (PDK1)","volume":"284","author":"Dettori","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/srep26142","article-title":"A small molecule inhibitor of PDK1\/PLC\u03b31 interaction blocks breast and melanoma cancer cell invasion","volume":"6","author":"Raimondi","year":"2016","journal-title":"Sci. Rep."},{"issue":"7152","key":"10.1016\/j.ijbiomac.2026.154405_bb0350","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature05933","article-title":"A transforming mutation in the pleckstrin homology domain of AKT1 in cancer","volume":"448","author":"Carpten","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0355","article-title":"3-phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib","volume":"6","author":"Meraz","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.628690","article-title":"Activation of PI3K\/AKT\/mTOR pathway causes drug resistance in breast cancer","volume":"12","author":"Dong","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.154405_bb0365","doi-asserted-by":"crossref","first-page":"16729","DOI":"10.1007\/s00432-023-05416-4","article-title":"SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1\/AKT axis","volume":"149","author":"Huang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154405_bb0370","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/sj.bjc.6604637","article-title":"A novel AKT3 mutation in melanoma tumours and cell lines","volume":"99","author":"Davies","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0375","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","article-title":"Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas","volume":"64","author":"Bellacosa","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semcancer.2017.04.014","article-title":"PDK1: at the crossroad of cancer signaling pathways","author":"Gagliardi","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154405_bb0385","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0390","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2017.01.036","article-title":"Amino acid transporter SLC38A3 promotes metastasis of non-small cell lung cancer cells by activating PDK1","volume":"393","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0395","first-page":"780","article-title":"Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKC\u03b4 promotes cellular survival and chemotherapeutic resistance","volume":"63","author":"Clark","year":"2003","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154405_bb0400","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.7314\/APJCP.2012.13.8.4147","article-title":"Silencing of PDK1 gene expression by RNA interference suppresses growth of esophageal cancer","volume":"13","author":"Yu","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154405_bb0405","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jcma.2014.05.014","article-title":"Analysis of prognostic factors for esophageal squamous cell carcinoma with distant organ metastasis at initial diagnosis","volume":"77","author":"Chen","year":"2014","journal-title":"J. Chin. Med. Assoc."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0410","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jcp.21616","article-title":"Metastasis and AKT activation","volume":"218","author":"Sheng","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154405_bb0415","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1042\/BST20140222","article-title":"Acute regulation of PDK1 by a complex interplay of molecular switches","volume":"42","author":"Calleja","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0420","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcp.2016.08.020","article-title":"Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia","volume":"118","author":"\u00d6sterroos","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0425","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj20021626","article-title":"Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm","volume":"370","author":"Newton","year":"2003","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020512","article-title":"Kinome profiling to predict sensitivity to MAPK inhibition in melanoma and to provide new insights into intrinsic and acquired mechanism of resistance","volume":"12","author":"Krayem","year":"2020","journal-title":"Cancers"},{"issue":"34","key":"10.1016\/j.ijbiomac.2026.154405_bb0435","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1038\/onc.2013.383","article-title":"Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of BrafV600E:: Pten\u2212\/\u2212melanoma","volume":"33","author":"Scortegagna","year":"2014","journal-title":"Oncogene"},{"issue":"5\u20136","key":"10.1016\/j.ijbiomac.2026.154405_bb0440","doi-asserted-by":"crossref","first-page":"169","DOI":"10.18632\/genesandcancer.109","article-title":"Short-form Ron is a novel determinant of ovarian cancer initiation and progression","volume":"7","author":"Moxley","year":"2016","journal-title":"Genes Cancer"},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.154405_bb0445","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-09-0820","article-title":"3-phosphoinositide\u2013dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma","volume":"69","author":"Maurer","year":"2009","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154405_bb0450","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/sj.bjc.6602862","article-title":"Elevated phosphorylation and activation of PDK-1\/AKT pathway in human breast cancer","volume":"93","author":"Lin","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0455","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0460","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.2337\/db07-1614","article-title":"MiR-375 targets PDK1 and regulates glucose-induced biological responses in pancreatic beta-cells","volume":"57","author":"El Quaamari","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0465","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10062","article-title":"Exosomal cargoes in oral squamous cell carcinoma: current findings and potential functions","volume":"8","author":"Zhao","year":"2020","journal-title":"PeerJ"},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.154405_bb0470","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1093\/emboj\/cdf551","article-title":"A phosphoserine\/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation","volume":"21","author":"Fr\u00f6din","year":"2002","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154405_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9100140","article-title":"Targeting PDK1 for chemosensitization of cancer cells","volume":"9","author":"Emmanouilidi","year":"2017","journal-title":"Cancers"},{"issue":"25","key":"10.1016\/j.ijbiomac.2026.154405_bb0480","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/onc.2015.393","article-title":"PDK1 promotes tumor growth and metastasis in a spontaneous breast cancer model","volume":"35","author":"Du","year":"2016","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.154405_bb0485","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.7150\/jca.63128","article-title":"Role of long intergenic non-protein coding RNA 00152 in pancreatic cancer glycolysis via the manipulation of the microRNA-185-5p\/Kr\u00fcppel-like factor 7 axis","volume":"12","author":"Li","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0490","first-page":"5597","article-title":"Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma","author":"Wang","year":"2016","journal-title":"Onco. Targets Ther."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154405_bb0495","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3324\/haematol.2013.096487","article-title":"The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts","volume":"99","author":"Zabkiewicz","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117722","article-title":"Nucleus-located PDK1 regulates growth, invasion and migration of breast cancer cells","volume":"253","author":"Gan","year":"2020","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0505","doi-asserted-by":"crossref","first-page":"101041","DOI":"10.1016\/j.gendis.2023.06.013","article-title":"PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1\u03b1","volume":"11","author":"Wei","year":"2024","journal-title":"Genes Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0510","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/13543776.2019.1597852","article-title":"A patent update on PDK1 inhibitors (2015-present)","volume":"29","author":"Sestito","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109239","article-title":"Rational design of next-generation PDK1 modulators: Addressing selectivity and resistance through molecular insights - A medicinal chemistry perspective","volume":"167","author":"Fu","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154405_bb0520","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/cmdc.200800195","article-title":"Small-molecule inhibitors of PDK1","volume":"3","author":"Peifer","year":"2008","journal-title":"ChemMedChem"},{"issue":"03","key":"10.1016\/j.ijbiomac.2026.154405_bb0525","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1160\/TH13-06-0484","article-title":"PDK1 selectively phosphorylates Thr (308) on Akt and contributes to human platelet functional responses","volume":"112","author":"Dangelmaier","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113797","article-title":"The kinase inhibitor BX795 suppresses the inflammatory response via multiple kinases","volume":"174","author":"Yu","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.154405_bb0535","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1074\/jbc.M109.000414","article-title":"Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and I\u03baB kinase \u03f5: a distinct upstream kinase mediates Ser-172 phosphorylation and activation","volume":"284","author":"Clark","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154405_bb0540","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/0008-5472.CAN-03-4063","article-title":"From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors","volume":"64","author":"Zhu","year":"2004","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154405_bb0545","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.18632\/oncotarget.7349","article-title":"Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function","volume":"7","author":"Booth","year":"2016","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.154405_bb0550","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1093\/emboj\/20.16.4380","article-title":"The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB","volume":"20","author":"Biondi","year":"2001","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154405_bb0555","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1158\/0008-5472.CAN-08-3839","article-title":"In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B\/AKT","volume":"69","author":"Moses","year":"2009","journal-title":"Cancer Res."},{"issue":"12 Suppl 2","key":"10.1016\/j.ijbiomac.2026.154405_bb0560","article-title":"PDK1 inhibitors SNS-229 and SNS-510 cause pathway modulation, apoptosis and tumor regression in hematologic cancer models in addition to solid tumors","volume":"14","author":"Hansen","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0565","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4155\/ppa.12.17","article-title":"PDK1 inhibitors","volume":"1","author":"Barile","year":"2012","journal-title":"Pharmaceut. Patent Anal."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0570","article-title":"Innovative PDK1-Degrading PROTACs Transform Cancer Aerobic Glycolysis and Induce Immunogenic Cell Death in Breast Cancer","volume":"5","author":"Deng","year":"2025","journal-title":"Exploration (Beijing)"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154405_bb0575","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00894-019-4069-5","article-title":"Discovery of SBF1 as an allosteric inhibitor targeting the PIF-pocket of 3-phosphoinositide-dependent protein kinase-1","volume":"25","author":"Liu","year":"2019","journal-title":"J. Mol. Model."},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.154405_bb0580","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1021\/jm070851i","article-title":"Discovery of dibenzo [c, f][2, 7] naphthyridines as potent and selective 3-phosphoinositide-dependent kinase-1 inhibitors","volume":"50","author":"Gopalsamy","year":"2007","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154405_bb0585","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13046-019-1191-2","article-title":"Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer","volume":"38","author":"Emmanouilidi","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.154405_bb0590","doi-asserted-by":"crossref","first-page":"39185","DOI":"10.18632\/oncotarget.16642","article-title":"PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1\/C2 inhibitor PP242","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154405_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002227","article-title":"Cooperative activation of PDK1 and AKT by MAPK4 enhances cancer growth and resistance to therapy","volume":"21","author":"Han","year":"2023","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154405_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24071363","article-title":"Ponatinib inhibits proliferation and induces apoptosis of liver cancer cells, but its efficacy is compromised by its activation on PDK1\/Akt\/mTOR signaling","volume":"24","author":"Liu","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0605","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/bj20031119","article-title":"Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition","volume":"375","author":"Komander","year":"2003","journal-title":"Biochem. J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154405_bb0610","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/sj.onc.1205225","article-title":"Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine)","volume":"21","author":"Sato","year":"2002","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.154405_bb0615","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/all.12763","article-title":"PDK 1\/Akt\/PDE 4D axis identified as a target for asthma remedy synergistic with \u03b22 AR agonists by a natural agent arctigenin","volume":"70","author":"Fang","year":"2015","journal-title":"Allergy"},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.154405_bb0620","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.1158\/1078-0432.CCR-04-0772","article-title":"7-hydroxystaurosporine (UCN-01) inhibition of Akt Thr308 but not Ser473 phosphorylation: a basis for decreased insulin-stimulated glucose transport","volume":"10","author":"Kondapaka","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154405_bb0625","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1200\/JCO.2005.03.116","article-title":"Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with fluorouracil in patients with advanced solid tumors","volume":"23","author":"Kortmansky","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154405_bb0630","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.324","article-title":"Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K\/Akt signaling pathway","volume":"4","author":"Deng","year":"2013","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0635","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3892\/or.2015.4029","article-title":"The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy","volume":"34","author":"Luo","year":"2015","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0640","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/08927022.2015.1021346","article-title":"Structural basis and energy landscape of apigenin-induced cancer cell apoptosis mechanism in PI3K\/Akt pathway","volume":"42","author":"Duan","year":"2016","journal-title":"Mol. Simul."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154405_bb0645","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-16-2653","article-title":"Kinome-wide RNA interference screen reveals a role for PDK1 in acquired resistance to CDK4\/6 inhibition in ER-positive breast cancer","volume":"77","author":"Jansen","year":"2017","journal-title":"Cancer Res."},{"issue":"4_Supplement","key":"10.1016\/j.ijbiomac.2026.154405_bb0650","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS15-PD2-06","article-title":"Abstract PD2-06: inhibition of 3-phosphoinositide dependent protein kinase 1 (PDK1) synergizes with CDK4\/6 inhibitors against ER-positive breast cancer","volume":"76","author":"Jansen","year":"2016","journal-title":"Cancer Res."},{"issue":"5712","key":"10.1016\/j.ijbiomac.2026.154405_bb0655","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.740796","article-title":"Carfilzomib: a promising proteasome inhibitor for the treatment of relapsed and refractory multiple myeloma","volume":"11","author":"Jayaweera","year":"2021","journal-title":"Front. Oncol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.154405_bb0665","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111492","article-title":"PDK1 inhibitor BX795 improves cisplatin and radio-efficacy in oral squamous cell carcinoma by downregulating the PDK1\/CD47\/Akt-mediated glycolysis signaling pathway","volume":"22","author":"Pai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0670","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2025.08.018","article-title":"Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase a\/d and Small Ubiquitin-Like Modifier Signaling in Pancreatic Cancer","volume":"170","author":"K\u00f6se","year":"2026","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154405_bb0675","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1158\/1078-0432.CCR-18-3276","article-title":"PDK1 mediates NOTCH1-mutated head and neck squamous carcinoma vulnerability to therapeutic PI3K\/mTOR inhibition","volume":"25","author":"Sambandam","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154405_bb0680","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41416-020-0889-4","article-title":"A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity","volume":"123","author":"Kostaras","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154405_bb0685","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/1535-7163.MCT-11-0936","article-title":"Antitumor mechanisms of targeting the PDK1 pathway in head and neck cancer","volume":"11","author":"Bhola","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.154405_bb0690","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131106","article-title":"Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma","volume":"4","author":"Lu","year":"2019","journal-title":"JCI Insight"},{"issue":"196","key":"10.1016\/j.ijbiomac.2026.154405_bb0695","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005747","article-title":"MTORC1 inhibition is required for sensitivity to PI3K p110\u03b1 inhibitors in PIK3CA-mutant breast cancer","volume":"5","author":"Elkabets","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154405_bb0700","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1158\/1078-0432.CCR-14-2034","article-title":"Idelalisib: first-in-class PI3K delta inhibitor for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma","volume":"21","author":"Yang","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154405_bb0705","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41389-020-0209-0","article-title":"PDK1 promotes ovarian cancer metastasis by modulating tumor-mesothelial adhesion, invasion, and angiogenesis via \u03b15\u03b21 integrin and JNK\/IL-8 signaling","volume":"9","author":"Siu","year":"2020","journal-title":"Oncogenesis"},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.154405_bb0710","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1158\/0008-5472.CAN-14-1420","article-title":"Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma","volume":"74","author":"Chinen","year":"2014","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154405_bb0715","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094435","article-title":"Deep learning in virtual screening: recent applications and developments","volume":"22","author":"Kimber","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.154405_bb0720","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1158\/0008-5472.CAN-21-3217","article-title":"A genome-wide screen identifies PDPK1 as a target to enhance the efficacy of MEK1\/2 inhibitors in NRAS mutant melanoma","volume":"82","author":"Cai","year":"2022","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154405_bb0725","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.chembiol.2016.06.017","article-title":"Bidirectional allosteric communication between the ATP-binding site and the regulatory PIF pocket in PDK1 protein kinase","volume":"23","author":"Schulze","year":"2016","journal-title":"Cell Chem. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154405_bb0730","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","article-title":"Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance","volume":"13","author":"Rozengurt","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2026.154405_bb0735","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-pharmtox-010715-103507","article-title":"Targeted protein degradation by small molecules","volume":"57","author":"Bondeson","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154405_bb0740","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026043515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026043515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:26:39Z","timestamp":1794493599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026043515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":148,"alternative-id":["S0141813026043515"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154405","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PDK1 signaling in cancer: Current status and future perspectives","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154405"}}